Cassava Sciences is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. From Wikipedia
The biotech firm’s experimental drug simufilam failed to demonstrate efficacy, leading to plummeting stock prices and a reevaluation of its future.
